A multidisciplinary journal devoted to safe and effective medication use in neonatal and pediatric patients. JPPT is the official journal of @PediatRxAssn.
The second commentary builds upon other inconsistencies that exist with a highlight on the downstream effects of recent public statements and media amplification.
https://t.co/rpE5txHQxA
Struggling to dispel public concerns about prenatal #acetaminophen and autism spectrum disorder at your practice site? Two commentaries were recently published with robust discussion on existing literature.
The first commentary summarizes the select studies that have been major drivers of the ongoing conversation and provide a close examination of the studies methodologies.
https://t.co/B8wEtx5JIU
Vaccines may no longer dominate the headlines, but federal efforts to challenge vaccine policy are still occurring. In a recent report, journalists @bylenasun and @rachel_roubein examined the ongoing efforts influencing vaccine policy behind the scenes. https://t.co/uqjvaDKJiv
Author Kam Sripada shares their thoughts on #microplastics and its threat to human rights and #child health in new commentary linked below. https://t.co/3BZUizVGru
TOMORROW—Be sure to catch this PPA educational opportunity! Learn more about Nicotine Pouch Toxicity in Pediatrics with Ty Schacher, PharmD, BCPPS, BCPS.
Register here before it's too late: https://t.co/gWCyHgnO8r
THIS WEEK—Be sure to catch this upcoming PPA educational opportunity! Learn more about Pediatric Pharmacogenomics Pearls: CPIC Guidelines and Beyond.
Register here before it's too late: https://t.co/Iwf6BNO53D
Inhaled tobramycin for prevention of ventilator associated #tracheitis in #pediatric patients resulted in 19% of individuals studied growing #resistant organisms on subsequent tracheal cultures. #pedsID
Inhaled tobramycin for prevention of ventilator associated #tracheitis in #pediatric patients resulted in 19% of individuals studied growing #resistant organisms on subsequent tracheal cultures. #pedsID
JPPT has worked with individuals at the Duke Clinical Research Institute Summer Training In Academic Research (#STAR) to provide a concentrated section of this year's completed projects focused on formulation, dosing, efficacy, and safety of drugs in pediatric patients.
JPPT has worked with individuals at the Duke Clinical Research Institute Summer Training In Academic Research (#STAR) to provide a concentrated section of this year's completed projects focused on formulation, dosing, efficacy, and safety of drugs in pediatric patients.
An overview of the program itself can be found here. The STAR Program includes students at varying levels (high school, college, medical/pharmacy/graduate school).
https://t.co/2cNAR1kzA8
Pharmacists are uniquely positioned to address vaccine misinformation through empathetic, evidence-based communication.
Check out the latest publication by the PPA Immunization Committee for a summary of communication strategies & shareable resources on childhood vaccines.
February 4th is World Cancer Day, let’s honour those we’ve lost, support those living with cancer, and raise awareness for better prevention and treatment options.
#WorldCancerDay#WorldCancerDay2026
We at JPPT hope everyone is staying safe and warm during this winter storm! We are happy to announce that we are releasing manuscripts ahead of print to give our readers some extra reading material between the formal publication cycles. 🌨️📕https://t.co/SXh2aKsVaU